Underlying mechanisms of multi-organ manifestations and exacerbated inflammation in
COVID-19 are yet to be delineated. The hypothesis of SARS-CoV-2 triggering autoimmunity …

Aim: To define the autoimmune potential of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection. Methods: Experimentally validated epitopes …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is associated
with increased levels of autoantibodies targeting immunological proteins such as cytokines …

Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of
reasons. Viruses are thought to be important environmental elements that contribute to the …

Following the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection, the importance of investigation of the pathogenesis and immunological …

Diverse autoantibodies were suggested to contribute to severe outcomes of COVID‐19, but
their functional implications are largely unclear. ACE2, the SARS‐CoV‐2 receptor and a key …

The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral …

SARS-CoV-2 infection can produce a variety of clinical manifestations, which are either
directly related to viral tissue damage or indirectly induced by the antiviral immune …

We aim to establish a comprehensive COVID-19 autoantigen atlas in order to understand
autoimmune diseases caused by SARS-CoV-2 infection. Based on the unique affinity …

We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2
protein antibodies and human tissue antigens, and whether molecular mimicry between …